SC 13G: JOHNSON & JOHNSON

AI Summary

SC 13G filing by JOHNSON & JOHNSON.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — Name of Issuer) Class A Common Stock, $0.001 par value (Title of Class of Securiti

Filing Documents

• s13g_040924-contineum.htm (SC 13G) — 50KB
• 0000904454-24-000255.txt ( ) — 52KB

(a)

ITEM 1(a) NAME OF ISSUER: Contineum Therapeutics, Inc.

(b)

ITEM 1(b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 10578 Science Center Drive, Suite 200 San Diego, CA 92121

(a)

ITEM 2(a) NAME OF PERSON FILING: This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Innovation-JJDC, Inc., a Delaware corporation (“JJDC”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC. The Joint Filing Agreement between J&J and JJDC is attached hereto as Exhibit A.

(b)

ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE: J&J: One Johnson & Johnson Plaza, New Brunswick, NJ 08933 JJDC: 410 George Street, New Brunswick, NJ 08901

(c)

ITEM 2(c) CITIZENSHIP: J&J: New Jersey JJDC: Delaware

(d)

ITEM 2(d) TITLE OF CLASS OF SECURITIES: Class A Common Stock, $0.001 par value (“Class A Common Stock”)

(e)

ITEM 2(e) CUSIP NUMBER: 21217B100 ITEM 3 Not applicable. CUSIP No. 21217B100 Page 5 of 7 ITEM 4 The information set forth in the cover pages of this Schedule 13G is incorporated herein by reference. Percentage ownership is based on 18,445,422 shares of Class A Common Stock outstanding after the closing of the Issuer’s initial public offering on April 9, 2024, as provided to the Reporting Persons by the Issuer. ITEM 5 Not applicable. ITEM 6 Not applicable. ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: Not applicable. ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9 NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10 CERTIFICATION: By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 21217B100 Page 6 of 7 SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: April 10, 2024 JOHNSON & JOHNSON By: /s/ Marc Larkins Name: Marc Larkins Title: Secretary JOHNSON & JOHNSON INNOVATION-JJDC, INC. By: /s/ Jill McManus Name: Jill McManus Title: Assistant Treasurer CUSIP No. 21217B100 Page 7 of 7 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is annexed

View Full Filing

View this SC 13G filing on SEC EDGAR